Analystreport

BioSpecifics Technologies Corp. (NASDAQ: BSTC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "strong sell" rating.

BIOSPECIFICS TECHNOLOGIES  (BSTC) 
Last biospecifics technologies earnings: 11/8 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: biospecifics.com